��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Rivastigmine Is a Potent Inhibitor of Cholinesterases in Plaques and Tangles

Topic

Presentation(s)

Poster/Presentation
Number 111

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Bhaskar Roy, MD, FAAN (Yale University)	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
	No disclosure on file
	No disclosure on file
Charles H. Whitaker, MD (Hospital for Special Care)	No disclosure on file
	No disclosure on file
Kevin Felice, DO (Hospital for Special Care)	No disclosure on file